4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-029616
CEO & President sold 9,086 shares at $25.85 ($234,873)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Brumm Joshua T CEO & President | 2024-03-07 | Sale 10b5-1 | −9,086 | $25.85 | $234,873 | 554,385 | D |
| Open-market sales · 9,086 sh · avg $25.85 · $234,873 | |||||||
Loading xslF345X05/ownership.xml…